Slide 1

Research Group Normal and Malignant Stem Cells

Andreas Trumpp
Group Leader

• Overview
• Normal Stem Cells
• Malignant Stem Cells
• Staff
• Alumni
• Publications

Lab News HSC Group

May 03, 2022

CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells

Apr 28, 2022

Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs.

Apr 28, 2022

Tumors on withdrawal: Amino acid deficiency shrinks childhood tumors

Apr 28, 2022

ERC Advanced Grant for Andreas Trumpp

Dec 14, 2021

High recognition for Andreas Trumpp

Sep 01, 2021

Ferroptosis: Mechanism and Diseases

Jun 10, 2021

Mouse multipotent progenitor 5 cells are located at the interphase between hematopoietic stem and progenitor cells

Mar 22, 2021

MutaSeq: Single-cell analysis of leukemic stem cells - Cooperation with Velten and Steinmetz Lab published in Nature Communications

Jan 27, 2021

How blood stem cells maintain their lifelong potential for self-renewal - New publication in Nature Communications

Dr. Simon Raffel

Hematopoietic and Leukemic Stem Cells

Clinician Scientist

Im Neuenheimer Feld 280 D-69120 Germany

This email address is being protected from spambots. You need JavaScript enabled to view it.

+49 6221 56-8611

https://www.klinikum.uni-heidelberg.de/zentrum-fuer-innere-medizin-medizin-klinik/innere-medizin-v-haematologie-onkologie-und-rheumatologie/forschung/emmy-noether-ag-raffel/

 

Simon Raffel has been a Postdoc at HI-STEM until 2018. Since then, he is running his own independent group at Heidelberg University Hospital. He remains affiliated with HI-STEM to continue cooperation projects.

Please find further information at his group website.